GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Current Deferred Revenue (2016 - 2018)

Updated

Gsk (GSK) posted Current Deferred Revenue of $274.18 million for the quarter ended Dec 31, 2018, down 15.0% from $322.58 million a year earlier.

Analysis

Gsk (GSK) Current Deferred Revenue (2016 - 2018) Analysis & Trends

  • In prior years, Gsk's Current Deferred Revenue was $322.58 million in the year ended Dec 31, 2017 (+66.1%) and $194.15 million in the year ended Dec 31, 2016.
  • The figure for the quarter ended Dec 31, 2018 stands as the lowest quarterly Current Deferred Revenue since the quarter ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn
4 Merck 370.60 Bn 370.60 Bn -
5 Novartis Ag 311.97 Bn 285.20 Bn -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 274.18 Mn
Dec 31, 2017 322.58 Mn
Dec 31, 2016 194.15 Mn
API Access

Gsk Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GSK&period=max&api_key=YOUR_API_KEY